{"id":1916236,"date":"2023-04-18T11:57:05","date_gmt":"2023-04-18T15:57:05","guid":{"rendered":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/jj-raises-annual-profit-forecast-on-cancer-drug-strength\/"},"modified":"2023-04-18T11:57:39","modified_gmt":"2023-04-18T15:57:39","slug":"jj-raises-annual-profit-forecast-on-cancer-drug-strength","status":"publish","type":"post","link":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/jj-raises-annual-profit-forecast-on-cancer-drug-strength\/","title":{"rendered":"J&amp;J raises annual profit forecast on cancer drug strength"},"content":{"rendered":"<aside class=\"mashsb-container mashsb-main mashsb-stretched\"><div class=\"mashsb-box\"><div class=\"mashsb-count mash-medium\" style=\"float:left\"><div class=\"counts mashsbcount\">18<\/div><span class=\"mashsb-sharetext\">SHARES<\/span><\/div><div class=\"mashsb-buttons\"><a class=\"mashicon-facebook mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/www.facebook.com\/sharer.php?u=https%3A%2F%2Fwww.conservativenewsdaily.net%2Fbreaking-news%2Fjj-raises-annual-profit-forecast-on-cancer-drug-strength%2F\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Facebook<\/span><\/a><a class=\"mashicon-twitter mash-medium mash-nomargin mashsb-noshadow\" href=\"https:\/\/twitter.com\/intent\/tweet?text=&amp;url=https:\/\/www.conservativenewsdaily.net\/breaking-news\/?p=1916236&amp;via=ConservNewsDly\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Twitter<\/span><\/a><a class=\"mashicon-subscribe mash-medium mash-nomargin mashsb-noshadow\" href=\"#\" target=\"_top\" rel=\"nofollow\"><span class=\"icon\"><\/span><span class=\"text\">Subscribe<\/span><\/a><div class=\"onoffswitch2 mash-medium mashsb-noshadow\" style=\"display:none\"><\/div><\/div>\n            <\/div>\n                <div style=\"clear:both\"><\/div><\/aside>\n            <!-- Share buttons by mashshare.net - Version: 4.0.47--><p> <!DOCTYPE html PUBLIC \"-\/\/W3C\/\/DTD HTML 4.0 Transitional\/\/EN\" \"http:\/\/www.w3.org\/TR\/REC-html40\/loose.dtd\"><?xml encoding=\"utf-8\" ?><html><body><\/p>\n<div class=\"entry-content\">\n<p>In an effort to offset the impact of declining sales of some of its older medications, Johnson &#038; Johnson increased its 2023 sales forecast on Tuesday. This was done by leveraging its more recent cancer treatments and Darzalex, a multiple myeloma medication.<\/p>\n<p>In 2023, the care company anticipates earning between$ 10.60 and$ 10.70 per share on adjusted terms, up from its previous estimate of between 10.00 and 10.05.65. According to Refinitiv data, analysts were anticipating a profit of$ 10.51 per share.<\/p>\n<div id=\"div-gpt-ad-1663871513696-art-1\" style=\"min-width: 320px; min-height: 50px; text-align: center;\"><script> googletag.cmd.push(function() { googletag.display('div-gpt-ad-1663871513696-art-1'); }); <\/script><\/div>\n<\/p>\n<p>As older treatments like Crohn&#8217;s&#8217;s disease drug Stelara face impending competition, J &#038; J is betting on the success of Darzalex and newer cancer medications like Carvykti and Tecvayli to bring it closer to its target of about$ 60 billion in drug sales by 2025.<\/p>\n<p>Additionally, the company is spinning off its individual health division.<\/p>\n<p>The drugmaker also reported better-than-expected first-quarter income of$ 2.68 per share, which was aided by strong business across its divisions, including individual health and medical devices. On average, analysts had anticipated a$ 2.50 per share profit.<\/p>\n<\/p>\n<p>( Reporting from Bengaluru by Bhanvi Satija and Manas Mishra, with Sriraj Kalluvila editing )<\/p>\n<p><a href=\"https:\/\/www.oann.com\/uncategorized\/jj-raises-annual-profit\/attachment\/file-photo-johnson-johnson-company-offices-are-shown-in-2\/\"><\/a><\/p>\n<\/div>\n<div class=\"entry-content\">\n<p>alongside Mark Lamb<\/p>\n<\/div>\n<div class=\"entry-content\">\n<p>Lee Williams is with<\/p>\n<\/div>\n<div class=\"entry-content\">\n<p>Steve Boulton is with<\/p>\n<\/div>\n<div class=\"entry-content\">\n<p>along with Lt. Col. Maginnis Rob<\/p>\n<\/div>\n<div class=\"entry-content\">\n<p>FRANKFURT ( Reuters )- Germany&#8217;s&#8217;s electric vehicle charging points increased by 35 % last year, outpacing the rate of growth.<\/p>\n<\/div>\n<div class=\"entry-content\">\n<p>Elon Musk, a billionaire, announced on Monday that he would introduce artificial intelligence ( AI ) by Hyunjoo Jin and Sheila Dang( Reuters ) in San Francisco.<\/p>\n<\/div>\n<div class=\"entry-content\">\n<p>Shares of Alphabet Inc. dropped as much as 4 % on Monday, according to( Reuters ) after a report that South Korea&#8217;s&#8217;s Samsung Electronics was considering taking over from Google&#8230;<\/p>\n<\/div>\n<div class=\"entry-content\">\n<p>Merdeka Battery Materials increased 11.3 % in its stock market debut on Tuesday by Bernadette Christina, Fransiska Nangoy, and Yantoultra Ngui JAKARTA \/ SINGAPORE( Reuters )-<\/p>\n<\/div>\n<p><\/body><\/html><\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Reuters) \u2013 Johnson &amp; Johnson on Tuesday raised its 2023 profit forecast, banking on its newer cancer treatments and multiple myeloma drug Darzalex to soften the blow from declining sales for some of its older drugs. The healthcare conglomerate now expects to earn between $10.60 and $10.70 per share on an adjusted basis for 2023<\/p>\n","protected":false},"author":66,"featured_media":1916237,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mo_disable_npp":"","fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","fifu_image_alt":"","footnotes":""},"categories":[542],"tags":[3888,8047,5642,16788,15948,7116,4224,10807],"class_list":["post-1916236","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-oann","tag-annual","tag-cancer","tag-drug","tag-forecast","tag-jj","tag-profit","tag-raises","tag-strength"],"fifu_image_url":"https:\/\/cndimages.nyc3.digitaloceanspaces.com\/breaking-news\/wp-content\/uploads\/2021\/01\/IMG_2758-scaled-1.jpg","_links":{"self":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/1916236","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/users\/66"}],"replies":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/comments?post=1916236"}],"version-history":[{"count":0,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/posts\/1916236\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media\/1916237"}],"wp:attachment":[{"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/media?parent=1916236"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/categories?post=1916236"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.conservativenewsdaily.net\/breaking-news\/wp-json\/wp\/v2\/tags?post=1916236"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}